As of Feb 24
| +0.28 / +0.62%|
The 14 analysts offering 12-month price forecasts for Abbott Laboratories have a median target of 48.00, with a high estimate of 51.00 and a low estimate of 41.00. The median estimate represents a +5.08% increase from the last price of 45.68.
The current consensus among 18 polled investment analysts is to Buy stock in Abbott Laboratories. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.